Clinical Trials Browser

Graft vs Host Disease, Neoplasms, Plasma Cell

NCT00900198 2026-04-14

Collection of Tissue Samples for Cancer Research

Recruiting

5,000 enrolled

LymphoidMyeloidPlasma cell

Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms

NCT02682667 2026-04-14

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

Recruiting

500 enrolled

LymphoidOther hematologic neoplasmOther neoplasmPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Precancerous Conditions, Leukemia-Lymphoma, Adult T-Cell

NCT03412877 2026-04-14

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

Phase 2 Recruiting

285 enrolled

BreastEndocrineGynecologicNETPlasma cellThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Multiple Myeloma, Ovarian Neoplasms, Urogenital Neoplasms, Neuroendocrine Tumors

NCT06103838 2026-04-14

18F-Fluciclovine PET/CT in Multiple Myeloma

Phase 2 Recruiting

60 enrolled

Plasma cell

Multiple Myeloma

NCT04847453 2026-04-13

Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis

Phase 1 Recruiting

24 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT06179888 2026-04-13

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

Phase 2 Recruiting

78 enrolled

Plasma cell

Multiple Myeloma

NCT06465316 2026-04-13

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

Phase 1 Recruiting

26 enrolled

Plasma cell

Multiple Myeloma

NCT01676805 2026-04-08

Tissue Collection for Studies of Lymph Cancer

Recruiting

1,295 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Multiple Myeloma, Leukemia-Lymphoma, Adult T-Cell

Clinical Trials

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

Collection of Tissue Samples for Cancer Research

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

18F-Fluciclovine PET/CT in Multiple Myeloma

Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

Tissue Collection for Studies of Lymph Cancer